Patents
Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939)
08/2002
08/28/2002EP0988300B1 Benzo(5,6)cyclohepta(1,2-b)pyridine derivatives for the inhibition of farnesyl protein transferase
08/27/2002US6441179 Intermediates useful for the preparation of antihistaminic piperidine derivatives
08/27/2002US6441178 Resolution of ritalinic acid salt
08/27/2002US6441177 (4-bromo-phenyl)-(4-(6-(cyclopropyl-methyl-amino)-hexyloxy)-2-fluoro -phenyl)-methanone; antimycotic and cholesterol lowering activity
08/27/2002US6441166 Sterically hindered amine compounds
08/27/2002US6441023 For therapy of arthritis, tumor metastasis, tissue ulceration, abnormal wound healing, periodontal disease, bone disease, diabetes (insulin resistance) and hiv infection
08/27/2002US6441001 2-substituted-4-nitrogen heterocycles as modulators of chemokine receptor activity
08/27/2002US6441000 Compounds useful in therapy
08/27/2002US6440997 −E-2-(3,4-dichlorocinnamyl)-1-cyclopropylmethylpiperidine, and its antidiarrhoeal use
08/27/2002US6440996 Monomeric and dimeric heterocycles, and therapeutic uses thereof
08/27/2002US6440937 Competitive inhibitors of trypsin-like serin proteases, especially thrombin and kininogenases such as kallikrein; thrombin inhibitors, anticoagulants, and antiinflammatory agents
08/27/2002US6440440 Biocidal benzylbiphenyl derivatives
08/22/2002WO2002064585A1 Synthesis method and intermediates of pyridin-2-yl-methylamine
08/22/2002WO2002064550A1 Glucocorticoid receptor modulators
08/22/2002WO2002064136A2 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators
08/22/2002WO2002064121A1 Novel modified released formulation
08/22/2002WO2002064118A1 Novel modified release formulation
08/22/2002WO2002032869A3 Substituted heterocyclic compounds for treating multidrug resistance
08/22/2002WO1999063992A9 Novel calcium channel drugs and uses
08/22/2002US20020115863 Hydroxamate derivatives that inhibit peptidyl deformylase (PDF), antimicrobials and antibiotics
08/22/2002US20020115755 Novel vinylic hindered amine light stabilizers
08/22/2002US20020115754 Monomer compatibility; reacting a hindered piperidine with an acryloyl chloride
08/22/2002US20020115715 Amine and amide derivatives as ligands for the neuropeptide Y Y5 receptor useful in the treatment of obesity and other disorders
08/22/2002US20020115671 Inhibitors of p38-a kinase
08/22/2002US20020115666 N-phenethyl-2-aryl-2-(4-(oxy-or amino-carbonylamino)piperidin-1-yl)acetamide derivatives
08/22/2002US20020115659 Compounds having heterocyclic groups containing two nitrogen atoms for treating multidrug resistance
08/22/2002CA2434835A1 Novel modified released formulation
08/22/2002CA2434542A1 Novel modified release formulation
08/21/2002EP1232150A1 Urea derivatives as anti-inflammatory agents
08/21/2002CN1365281A Metalloprotease inhibitors
08/21/2002CN1089337C 1,4-dihydropyridine derivatives
08/20/2002US6437137 Naphthyl compounds, intermediates, processes, compositions, and methods
08/20/2002US6437136 Bromide salt formation and bromination of 1-methylpiperidin-4-one, reaction with 1,3,5-trimethoxybenzene, catalytic hydrogenation to cis compound; chemical intermediate in synthesis of flavopiridol
08/20/2002US6436961 Substance p receptor antagonist; 2-phenyl-3-benzylaminopiperidines
08/20/2002US6436959 Delta-opioid receptor agonists/antagonists, analgesics
08/20/2002US6436928 Selective neurokinin antagonists
08/20/2002US6436152 Substituted 2-aminoalky-1,4-diaminobenzene compounds and oxidation dye precursor compositions containing same
08/20/2002CA2216129C Lactam-containing hydroxamic acids
08/20/2002CA2063886C Polyethylene protein conjugates
08/15/2002WO2002062885A2 Polymeric articles containing hindered amine light stabilizers based on multi-functional carbonyl compounds
08/15/2002WO2002062784A1 Piperidinee derivatives as neurokinin 1 antagonists
08/15/2002WO2002062748A1 Carboxylic amides, the production and use thereof as medicaments
08/15/2002WO2002062324A2 A treatment of oesophageal motility disorders and gastro-oesophageal reflux disease
08/15/2002WO2002062308A2 Primary intermediates for oxidative coloration of hair
08/15/2002WO2002047685A3 Nmda receptor agonist pharmaceutical compositions
08/15/2002WO2002042265A3 Cyanoguanidine prodrugs
08/15/2002US20020111513 Novel antihistaminic piperidine derivatives and intermediates for the preparation thereof
08/15/2002US20020111494 N-type calcium channel blockers, antiischemic agents
08/15/2002US20020111461 Peptidomimetic compound for us ein the treatment of diabetes
08/15/2002US20020111366 Therapy for brain disorders; strokes
08/15/2002US20020111347 Nervous system disorders
08/15/2002US20020111340 Antiallergens
08/15/2002CA2437380A1 A treatment of oesophageal motility disorders and gastro-oesophageal reflux disease
08/15/2002CA2436837A1 Carboxylic acid amides, the preparation thereof and their use as pharmaceutical compositions
08/15/2002CA2433378A1 Primary intermediates for oxidative coloration of hair
08/14/2002EP1230219A1 Aromatic sulfons hydroxamic acid metalloprotease inhibitor
08/14/2002EP0722439B1 Hiv protease inhibitors
08/14/2002CN1364158A Mutilin derivatives and their use as antibacterials
08/14/2002CN1364156A Novel naphthalene ureas as glucose uptake enhancers
08/14/2002CN1364155A N-Cyanomethyl amides as protease inhibitors
08/13/2002US6433182 Nitrosated and nitrosylated α-adrenergic receptor antagonist compounds, compositions and their uses
08/13/2002US6433178 3-alkyl-3-phenyl-piperidines
08/13/2002US6433165 Chemokine receptor antagonists and methods of use therefor
08/13/2002US6432985 4-benzyl-1-(2-(p-hydroxyphenoxy)ethyl)piperidine-3,4-diol; preparation from 1-(2-haloethoxy)-4-benzyloxybenzene and 4-benzylpiperidine-3,4-diol
08/13/2002US6432981 Cyclopentyl modulators of chemokine receptor activity
08/13/2002US6432960 Anorexogenic agents to promote weight loss and treat eating disorders
08/13/2002CA2189000C Process and diastereomeric salts useful for the optical resolution of racemic .alpha.-[4-(1,1-dimethylethyl)phenyl]-4-(hydroxydiphenylmethyl)-1-piperidinebutanol and derivative compounds
08/08/2002WO2002060894A2 Sulfonamide lactam inhibitors of factor xa
08/08/2002WO2002060873A1 3-(3-amidinophenyl)-5-[({[1-(1-(-iminoethyl)-4-piperidyl}amino)methyl]benzoic acid dihydrochloride and process for preparing the same
08/08/2002WO2002060861A1 Benzamidine derivatives and process for production thereof
08/08/2002WO2002060859A2 Cyclic derivatives as modulators of chemokine receptor activity
08/08/2002WO2002060858A1 Novel compound having maillard reaction inhibitory activity
08/08/2002WO2002060388A2 Acyl sulfamides for treatment of obesity, diabetes and lipid disorders
08/08/2002WO2002006189A3 Aniline derivatives
08/08/2002WO2002002744A3 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof
08/08/2002WO2002002518A3 Compounds to treat alzheimer's disease
08/08/2002WO2001098268A3 Piperidine amides as modulators of chemokine receptor activity
08/08/2002US20020107397 Provide polymeric resin products having low polydispersity.
08/08/2002US20020107290 Inhibiting activated blood-coagulation factor X
08/08/2002US20020107257 Treatments for restless legs syndrome
08/08/2002US20020107241 N-heterocyclic derivatives useful for treating or preventing neuronal damage associated with neurological disease
08/08/2002US20020107239 Cyclized amide derivatives
08/08/2002US20020107235 Carbamate and hydroxy groups containing phenanthrene derivatives; useful to treat obesity, diabetes and inflammation
08/08/2002DE10104598A1 Carbonsäureamide, deren Herstellung und deren Verwendung als Arzneimittel Carboxamides, their preparation and their use as medicaments
08/08/2002CA2436774A1 Sulfonamide lactam inhibitors of factor xa
08/08/2002CA2436265A1 3-(3-amidinophenyl)-5-[({[1-(1-iminoethyl)-4-piperidyl]methyl}amino)methyl]benzoic acid dihydrochloride and process for preparing the same
08/08/2002CA2434491A1 Acyl sulfamides for treatment of obesity, diabetes and lipid disorders
08/08/2002CA2432369A1 Cyclic derivatives as modulators of chemokine receptor activity
08/07/2002EP1229010A1 Novel diarylamide derivatives and use thereof as medicines
08/07/2002EP1228367A2 Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereof
08/07/2002EP1228060A1 Arylalkane, arylalkene and aryl azaalkane, medicaments containing said compounds and method for the production thereof
08/07/2002CN1362954A Sulfamato hydroxamic acid metalloprotease inhibitor
08/07/2002CN1362947A N-cyanomethylamides as protease inhibitors
08/07/2002CN1362407A Glutarimide compound S632A3 and its prepn and application in preparing medicine for treating viral infection and tumor
08/07/2002CN1088698C Micro-particulate form of tetrahydropyridin derivatives
08/07/2002CN1088697C Sterically hindered-4-amino-piperidine with low dimer content, its preparation method and use
08/06/2002US6429328 Processes and intermediate compounds for preparing guanidine and amidine derivatives
08/06/2002US6429317 Indane derivatives for antipsychotic compositions
08/06/2002US6429213 Cyclic hydroxamic acids as metalloproteinase inhibitors
08/06/2002CA2208682C Fibrinogen receptor antagonists having substituted .beta.-amino acid residues and pharmaceutical compositions comprising the same